Search Results 1071-1080 of 17716 for corticosteroid

1. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   ... corticosteroids at physiological replacement dose, equivalent to ≤ 10 mg prednisone daily. Steroids with no or minimal systemic effect (topical, inhalation) ...

2. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   NOTE: Prior treatment with corticosteroids (maximum dose of corticosteroids should not exceed the equivalent of 160 mg of dexamethasone over 14 days.

3. (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis - Mayo Clinic

   ... corticosteroids, or omalizumab. Patients must have BSC for ISM symptom ... 1 for more information on use of corticosteroid use during patient screening).

4. Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma - Mayo Clinic

   ... corticosteroids before treatment; Participant has had radiation therapy within 14 days of randomization; Participant has known chronic obstructive pulmonary ...

5. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... corticosteroids for reasons other than treatment of autoimmune complications is allowed; No other active primary malignancy (other than non-melanomatous skin ...

6. Visiting Medical Student Clerkships - Internal Medicine, Rheumatology Outpatient Service (Florida)

   ... corticosteroids and disease modifying agents. Perform an arthrocentesis during the rotation. Activity outline. 8:00 a.m. - 5:00 p.m. Students will be at the ...

7. Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA - Mayo Clinic

   ... corticosteroids 17. Current tobacco product use, including nicotine patch or other nicotine products 18. Clinically significant systemic inflammatory ...

8. A Study to Evaluate TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Hormone therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered an ...

9. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   No concomitant anti lymphoma therapy, including systemic corticosteroids for the purpose of treatment of lymphoma are allowed. Topical steroids are allowed ...

10. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Treatment with rituximab and/or high dose corticosteroids for ... Patients must not require more than 20 mg prednisone or equivalent corticosteroid daily.